Peripartum cardiomyopathy (PPCM) is a global disease with significant morbidity and
mortality, and Nigeria probably has the highest burden of the disease in the world.
Unfortunately, much about the disease including its aetiology, epidemiology and treatment is
not yet well described. This will be a prospective, national, multicenter cohort study,
conducted in centres in Nigeria. It is expected that approximately 500 patients with PPCM and
500 apparently healthy pregnant women will be recruited over a 6-month period with follow‐up
at 3-monthly intervals for 18 months.